Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0F4AN
|
||||
Former ID |
DNC007464
|
||||
Drug Name |
MCL-432
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528655] | ||
Structure |
Download2D MOL |
||||
Formula |
C24H34N2O2
|
||||
Canonical SMILES |
CCNC(=O)OC1=CC2=C(CC3C4C2(CCCC4)CCN3CC5CCC5)C=C1
|
||||
InChI |
1S/C24H34N2O2/c1-2-25-23(27)28-19-10-9-18-14-22-20-8-3-4-11-24(20,21(18)15-19)12-13-26(22)16-17-6-5-7-17/h9-10,15,17,20,22H,2-8,11-14,16H2,1H3,(H,25,27)
|
||||
InChIKey |
CDJRHRPFKCSONV-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Delta-type opioid receptor | Target Info | Inhibitor | [528655] | |
Kappa-type opioid receptor | Target Info | Inhibitor | [528655] | ||
Mu-type opioid receptor | Target Info | Inhibitor | [528655] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Enkephalin release | |||||
Opioid proenkephalin pathway | |||||
Opioid proopiomelanocortin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Opioid prodynorphin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.